Navigation Links
R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
Date:10/6/2009

TOKYO, Oct. 6 /PRNewswire/ -- R-Tech Ueno, Ltd. has started early Phase II clinical trial for RK-023, a physiologically active fatty acid derivative developed by the company -- a new compound targeted as a treatment for androgenetic alopecia (male pattern baldness) (Note 1).

Phase I clinical trial in healthy male volunteers that began in 2008 demonstrated the safety of RK-023 (Note 2). Early phase II clinical trial has been started for two purposes. One is to evaluate the safety of RK-023 for long-term use by men with pattern baldness. The other is to examine the preliminary effectiveness of this compound on hair growing. This clinical trial will be a double blind (Note 3), placebo-controlled (Note 4) study in which the study drug is applied to the scalp for 13 consecutive weeks.

"I am very pleased that early phase II clinical trial for RK-023 has started," said Dr. Yukihiko Mashima, president of R-Tech Ueno. "This is a compound that we are developing on our own for the treatment of male pattern baldness, which is part of our core dermatology operations. We plan to proceed with development activities quickly while conducting negotiations concerning alliances with companies in Japan and overseas."

R-Tech Ueno determines to complete the development of RK-023, quickly in order to provide assistance as soon as possible to men who are troubled by the loss of hair.

Notes:

  1. Androgenetic alopecia (male pattern baldness) is also called common baldness with aging. Following puberty, male hormones can prevent the regeneration of thick, long hair starting at the top of the skull and spreading forward. This hair is gradually replaced with thin, short hair. Eventually, this process leads to the atrophy of hair follicles and a decline in the number of strands of hair. Men first experience thinning of their hair and then baldness. This condition affects about 12 million men in Japan.
  2. See the R-Tech Ueno pres
    '/>"/>

SOURCE R-Tech Ueno, Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
2. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
4. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
5. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
6. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
7. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
8. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
9. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
10. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
11. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  The investigational S- equol nutritional supplement may ... such as hot flashes, according to a new peer-reviewed ... .[i] "Current data suggest that women may ... symptoms and possibly additional benefits, such as skin health. ... physicians and health care professionals may consider the use ...
(Date:3/30/2015)... March 30, 2015  Building on the momentum of the ... provider of medical alert systems, has announced aggressive plans to ... program and Managed Care business models. The first ... , Tennessee and Louisiana ... regional contracts to span statewide coverage in each state. This ...
(Date:3/30/2015)... DUBLIN , March 30, 2015 Perrigo ... global provider of "Quality Affordable Healthcare Products®," today announced ... Pharma Invest N.V. ("Omega") in a cash and equity ... assumption of €1.3 billion in debt. Sellers are ... and co-investors of Waterland.    ...
Breaking Medicine Technology:New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 2New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 3New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 4New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 5New Scientific Review Suggests Some Women May Benefit from Considering Use of S-equol to Ease Menopause Symptoms 6MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5
... - ImmunoVaccine Technologies, (IVT),patented depot vaccine formulation, ... efficacy achieved in therapeutic,cancer and several infectious ... will be presented October 4th at the ... University of Miami will also be reporting,on ...
... their ... risks, DAYTON, ... an estimated 182,460 new cases of breast,cancer will be diagnosed in American ... of the disease when it is,more easily and successfully treated, breast cancer ...
Cached Medicine Technology:ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 2Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 3Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center 4
(Date:3/30/2015)... GoHooper.com announces new website for Grace Pediatrics. Grace ... infants, children and adolescents and partners with parents to ... owner/provider Mark Hughes, MD, FAAP and a his team ... in the extensive range of pediatric care from newborn ... who meet the medical field's highest standards, and who ...
(Date:3/30/2015)... (PRWEB) March 31, 2015 Healtheminds, a ... wellness services through an innovative, easy to use and ... to create awareness about mental health related issues. The ... addiction to alcohol, tobacco and other drugs. , ... adverse health effects. These include the toxic effects of ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Wimbledon Health ... vascular, echocardiogram and NCV testing, ... affiliated physicians in observance of National Doctor’s Day. ... around our office, but on this day, we like ... important role they play in healing patients, promoting overall ...
(Date:3/30/2015)... OH (PRWEB) March 30, 2015 Wright ... product liability lawsuits, notes that the number of ... multidistrict litigation underway in U.S. District Court, District of ... in December 2014. "According to an update released by ... March 16th, at least 493 Syngenta lawsuits are now ...
(Date:3/30/2015)... Birmingham, Alabama (PRWEB) March 30, 2015 ... Modern Healthcare magazine ranked Robins & Morton sixth among ... 2014 revenues. Robins & Morton has specialized in healthcare ... history. , Robins & Morton ranked on the ... projects in 2014. The company built 2.6 million square ...
Breaking Medicine News(10 mins):Health News:Nashville Web Design Company Announces New Site Launch For Pediatrics Doctor 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Wimbledon Health Partners Recognizes National Doctors’ Day 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:Modern Healthcare Ranks Robins & Morton No. 6 Contractor 2
... ... today announced the new Skokie store opening mid-June will introduce the ... combines cardio workouts with brain workouts. Powered by Brain Center America,s ... recumbent stationary bike coupled with an interactive brain training program displayed ...
... The American Society of Hematology (ASH) announces the ... Student Award Program (MMSAP), which encourages minority medical students ... program, each award recipient will receive the support of ... stipends to attend the ASH annual meeting, and a ...
... improved in Swedish middle-aged women during the past 30 ... significantly. These are the of a thesis ,presented at ... study is part of the Prospective Population Study of ... the end of the 1960s, when 1,462 middle-aged women ...
... 2009) The American Society of Hematology (ASH) announces ... Medical Student Award Program (MMSAP), which encourages minority medical ... the program, each award recipient will receive the support ... travel stipends to attend the ASH annual meeting, and ...
... , MENTOR, Ohio, June 5 Join STERIS Isomedix ... topics critical to success in medical device sterilization ... September 23, will provide attendees the opportunity to learn about ... , In addition to the TechTeam experts from STERIS ...
... the U.S. leader in pain prescription monitoring, has announced the ... Managed Care Contracting. Hurley will oversee the company,s contracting ... , "We are thrilled to have Sean on board," said ... our ongoing commitment to provide our payors with both data ...
Cached Medicine News:Health News:Marbles: The Brain Store Opens New Location in Chicago, Introduces World's First Bike that Trains Body and Brain 2Health News:Marbles: The Brain Store Opens New Location in Chicago, Introduces World's First Bike that Trains Body and Brain 3Health News:Minority Medical Students Receive Support to Pursue Hematology Research 2Health News:Minority Medical Students Receive Support to Pursue Hematology Research 3Health News:Middle-aged women experience more stress but have lower blood pressure 2Health News:Minority medical students receive support to pursue hematology research 2Health News:Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 2Health News:Medical Device Sterilization Seminar Offered by STERIS Isomedix Services 3Health News:Sean Hurley Joins Ameritox as Vice President for Insurance and Managed Care Contracting 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: